Targeted cancer therapy: initial high concentration may slow down selection for resistance - ecancer
ecancer,
On July 28, 2024, Mikhail V. Blagosklonny M.D., Ph.D., fromRoswell Park Comprehensive Cancer Centerpublished a new editorial…
On July 28, 2024, Mikhail V. Blagosklonny M.D., Ph.D., fromRoswell Park Comprehensive Cancer Centerpublished a new editorial…
On July 28, 2024, Mikhail V. Blagosklonny M.D., Ph.D., from Roswell Park Comprehensive Cancer Center published a new editorial…
Credit: 2024 Blagosklonny et al. BUFFALO, NY- August 6, 2024 – On July 28, 2024, Mikhail V.
BUFFALO, NY- August 6, 2024 – On July 28, 2024, Mikhail V. Blagosklonny M.D., Ph.D., from Roswell Park Comprehensive Cancer…
“Unfortunately, any targeted therapy is, always, started with low levels of the drug in the organism, selecting for drug…
BUFFALO, NY- August 6, 2024 – On July 28, 2024, Mikhail V. Blagosklonny M.D., Ph.D., from Roswell Park Comprehensive Cancer…
Announcements Press Releases Altmetric Top 100 08-06-2024 BUFFALO, NY- August 6, 2024 – On July 28, 2024, Mikhail V.
“Unfortunately, any targeted therapy is, always, started with low levels of the drug in the organism, selecting for drug…